Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.05, indicating minimal leverage. The company's liquidity position is characterized by a current ratio of 2.76, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -475.78 million INR, which may indicate that capital expenditures are outpacing cash inflows. In terms of profitability, the company's return on equity is 0.77% and return on assets is 0.68%, which are relatively low. These figures suggest that the company is not generating substantial returns on its equity or assets compared to industry benchmarks. The operating income of 66.72 million INR and net income of 57.13 million INR further highlight the company's modest profitability. The company operates through a single segment, the Specialty chemical segment, and serves a diverse range of industries. However, the financial data does not provide specific details on geographic revenue concentration or segment performance. The company's operations are based in India, with manufacturing facilities in Gujarat, and it has subsidiaries in Europe and the USA, indicating some international exposure. The company's growth trajectory is not clearly defined in the provided data. The financial snapshot does not include historical revenue data or future outlook projections. Analyst estimates suggest a mean price target of 1,390.00 INR and a median price target of 1,380.00 INR, with a mean recommendation of 3.25, indicating a mixed outlook from analysts. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could pose a liquidity challenge. The dilution risk is low, suggesting that the company is not expected to issue additional shares in the near term. The company's capital structure and financial performance suggest that it is not currently facing significant dilution pressures. Recent events and filings do not provide specific details on the company's recent activities or strategic initiatives. The financial data does not include information on recent acquisitions, partnerships, or other significant events that could impact the company's performance. The company's operations and financial performance are primarily influenced by its ability to maintain and grow its market share in the specialty chemicals industry.